Henry Schein Inc banner

Henry Schein Inc
XMUN:HS2

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
XMUN:HS2
Watchlist
Price: 58.25 EUR -3.32% Market Closed
Market Cap: €7.6B

Henry Schein Inc
Investor Relations

Henry Schein is a distributor and service provider for dental and medical practices. It sells everyday consumable supplies, lab products, instruments, and larger equipment that clinics use to treat patients, along with software and business services that help offices run smoothly. It sits in the middle of the healthcare supply chain, moving products from manufacturers to small and mid-sized practices that need a one-stop source. Its main customers are dentists, dental labs, animal health practices, and physician offices, with dentistry as the company’s core market. Henry Schein makes money by buying products from manufacturers and reselling them to customers, while also earning fees from equipment service, practice management software, and related support services. Because many customers rely on regular replenishment and ongoing technical help, a lot of its business is repeat and relationship-based. What makes Henry Schein different is the mix of distribution and hands-on practice support. It does not just ship boxes of supplies; it also helps customers choose equipment, install it, maintain it, and manage parts of their office workflow. That makes the company more than a wholesaler and gives it a practical role in helping independent healthcare practices operate day to day.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 5, 2026
AI Summary
Q1 2026

Strong start: Henry Schein said first-quarter sales were $3.4 billion, up 6.3%, with stronger U.S. dental and global technology performance offsetting softer medical demand.

Margins improved: Gross margin and operating margin both expanded, and management said early value-creation benefits are starting to show up in the numbers.

Guidance unchanged: Full-year 2026 guidance stayed the same, with sales growth expected to be about 3% to 5% and EPS of $5.23 to $5.37.

Dental strength: Management said dental markets remain healthy, procedure volumes are steady, and Henry Schein is gaining share, helped by pricing, own brands, and DSO demand.

Medical softness: Medical growth was held back by weaker point-of-care diagnostic test sales tied to a light flu season, though Home Solutions and dialysis were strong.

AI and tech push: The company highlighted new AI offerings, a growing cloud software customer base, and a broader push to improve execution and accelerate growth.

Key Financials
Sales
$3.4 billion
Operating margin
5.41%
Operating margin
7.53%
Net income
$107 million
EPS
$0.92
EPS
$1.32
Adjusted EBITDA
$289 million
Global sales growth
6.3%
Cloud-based customers
roughly 25% year-over-year increase
Subscribers
more than 13,000
Share repurchases
approximately 1.6 million shares
Share repurchase cost
$125 million
Operating cash flow
negative $97 million
Restructuring expenses
$12 million
Remeasurement gain
$11 million
Operating income improvement target
more than $200 million annually
Earnings Call Recording
Other Earnings Calls

Management

Mr. Stanley M. Bergman CPA
Executive Chairman & CEO
No Bio Available
Mr. James P. Breslawski CPA
President
No Bio Available
Mr. Ronald N. South
Senior VP & CFO
No Bio Available
Mr. Michael Saul Ettinger
Executive VP & COO
No Bio Available
Mr. Mark E. Mlotek
Executive VP, Chief Strategic Officer & Executive Director
No Bio Available
Ms. Olga Timoshkina
VP of Corporate Finance, Chief Accounting Officer & Corporate Controller
No Bio Available
Mr. Christopher Pendergast
Senior VP & CTO
No Bio Available
Mr. Graham Stanley
VP of Investor Relations & Strategic Finance Project Officer
No Bio Available
Mr. Walter Siegel
Senior VP & Chief Legal Officer
No Bio Available
Ms. Ann Marie Gothard
Vice President of Global Corporate Media Relations
No Bio Available

Contacts

Address
NEW YORK
Melville
135 Duryea Rd
Contacts
+16318435500.0
www.henryschein.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett